The record
Written from the 1 report below. Nothing here is unsourced.
- Pharmacy chain MedPlus has changed its sales approach after admitting that staff went overboard in promoting its own private-label medicines.
- The company said the problem arose because employees were heavily incentivised to recommend its own brands.
- The change matters for customers because it affects how medicines are recommended at the counter.
What to watch next
- Details of MedPlus's revised sales strategy and staff incentive structure
- Any regulatory scrutiny or action over private-label promotion practices
- Impact of the change on MedPlus's private-label sales and earnings
Coverage1
1 report
English national1
All filed from India
Named India · MedPlus Staff · MedPlus
The 1 report is listed beside the record.
Ask this story
Answers cite the reports above, or say they can't.